Our Mission: Highlighting Innovations by showcasing breakthroughs in cancer research, including diagnostic tools, therapies, and preventive measures.

Treatment Innovations

Innovations in cancer treatment are transforming patient care by introducing more precise, effective, and less invasive therapies. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, has revolutionized cancer care by harnessing the immune system to target and destroy cancer cells.

MEDICAL XPRESS

Phase III trial finds trastuzumab emtansine improves long-term survival in HER2 breast cancer

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and improved survival compared to trastuzumab alone, according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center.

Read More »
KNOW RIDGE

Proton therapy is a softer approach to fighting cancer

Cancer treatment has come a long way in recent years, with researchers working tirelessly to find methods that are both effective and less harsh on patients. One of the most promising advancements is proton therapy, a type of radiation treatment that targets cancer cells with remarkable precision while sparing healthy tissues. This gentler approach is […]

Read More »
MEDICAL XPRESS

Kidney cancer study identifies factors for exceptional response to immunotherapy

Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, has historically presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, can lead to exceptional, durable responses (when the tumor substantially shrinks for a very long period of time) for some patients with mccRRC, allowing them to live longer with a better quality of life. However, the molecular reasons behind these exceptional responses have not been well defined.

Read More »
error: Content is protected !!